Hepatitis C Stocks

Description:

This portfolio consists of public companies that are researching a cure for Hepatitis C which affects 170 million people worldwide

"The hottest area in drug development right now and for the next couple of years is hepatitis C," said Kris Jenner, whow runs the $1.7 billion T. Rowe Price Health Sciences Fund.
Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

5 Stocks Set to Soar on Bullish Earnings

09.30.14 | 02:34 PM

DELAFIELD, Wis. (Stockpickr) -- Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a tra...

Buy These 5 Momentum Movers to Stomp the S&P

09.30.14 | 12:12 PM

BALTIMORE (Stockpickr) -- Now that five of the last seven sessions have ended lower in the S&P 500, Mr. Market is giving is a reminder that stock ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter